MYD88 and atherosclerosis: In human atheroma cell cultures blockade of TLR2 and MyD88 inhibits NF-κB activation and matrix metalloproteinase (MMP) production, suggesting that MyD88-mediated TLR2 signaling contributes to human atherosclerosis [48].